戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 f a quinonoid intermediate upon binding of 5-aminolevulinate.
2 cinyl-CoA to form CoA, carbon dioxide, and 5-aminolevulinate.
3 t that forms a quinonoid intermediate with 5-aminolevulinate.
4 termediate in the presence of the product, 5-aminolevulinate.
5 A to yield coenzyme A, carbon dioxide, and 5-aminolevulinate.
6 -CoA and glycine are condensed to generate 5-aminolevulinate (ALA) by a dedicated PLP-dependent ALA s
7 ession of the mammalian genes encoding delta-aminolevulinate (ALA) dehydratase and porphobilinogen de
8 yde (GSA), 4,5-diaminovalerate (DAVA), and 5-aminolevulinate (ALA) indicated various transient chromo
9 functional NRF-1 binding site from the delta-aminolevulinate (ALA) synthase promoter.
10                                            5-Aminolevulinate (ALA), an essential metabolite in all he
11 ulated high levels of hepatic URO when fed 5-aminolevulinate (ALA).
12 and succinyl-CoA to generate CoA, CO2, and 5-aminolevulinate (ALA).
13 li HB101 grown in LB medium containing delta-aminolevulinate and Fe(NO3)3 has a red color, while the
14 use of newer fluorescence agents (hexylester aminolevulinate and hypericin) and their application to
15 ns and protein fluorescence quenching upon 5-aminolevulinate binding demonstrated that the protein co
16 enol that is in rapid equilibrium with the 5-aminolevulinate-bound quinonoid species.
17 f glycine and succinyl coenzyme A produces 5-aminolevulinate, coenzyme A, and carbon dioxide.
18             Incremental differences in delta-aminolevulinate dehydratase (ALA-D; the second enzyme of
19  structure of the gene encoding murine delta-aminolevulinate dehydratase (ALAD; EC4.2.1.24), which is
20                     PBGS, also called "delta-aminolevulinate dehydratase," is encoded by the ALAD gen
21 d in this organism; however, an NADPH-linked aminolevulinate dehydrogenase activity was demonstrated.
22 rsion of aminolevulinate from the pathway by aminolevulinate dehydrogenase.
23                                    Decreased aminolevulinate delta, synthase 2 (ALAS2) levels attribu
24 observed that mutant cells were resistant to aminolevulinate-dependent toxicity, as expected if the h
25 of aminolevulinate synthase and diversion of aminolevulinate from the pathway by aminolevulinate dehy
26 stration, and aminolevulinic acid and methyl aminolevulinate have been approved for topical use.
27 d aminolevulinic acid hydrochloride ormethyl aminolevulinate hydrochloride as stabilizers with 10 or
28  pretreatment, followed by 3 hours of methyl aminolevulinate hydrochloride incubation and subsequent
29 yl-CoA to produce carbon dioxide, CoA, and 5-aminolevulinate, in a reaction cycle involving the mecha
30 reaction of 5-aminolevulinate with ALAS is 5-aminolevulinate-independent, suggesting that it also rep
31 iverged in the presence of either glycine or aminolevulinate, indicating that the reorientation of th
32       The primary outcome measure was methyl aminolevulinate-induced PPIX fluorescence accumulation.
33 rophyll, suggesting that the majority of the aminolevulinate is diverted from the common tetrapyrrole
34 est that turnover is limited by release of 5-aminolevulinate or a conformational change associated wi
35 in, which can only grow in the presence of 5-aminolevulinate or when it is transformed with an active
36                                       Methyl aminolevulinate photodynamic therapy has been effective
37 ly, the carbonyl and carboxylate groups of 5-aminolevulinate play a major protein-interacting role by
38 glycine binding before succinyl-CoA and with aminolevulinate release after CoA and carbon dioxide.
39 or a conformational change associated with 5-aminolevulinate release.
40  similar to that formed in the presence of 5-aminolevulinate, suggesting that release of this product
41 urther increased the activities of hepatic 5-aminolevulinate synthase (ALAS) and CYP1A2.
42                                            5-Aminolevulinate synthase (ALAS) catalyzes the first step
43                                            5-Aminolevulinate synthase (ALAS) catalyzes the first step
44                                            5-Aminolevulinate synthase (ALAS) catalyzes the first step
45                                            5-Aminolevulinate synthase (ALAS) is the first enzyme of t
46                                            5-Aminolevulinate synthase (ALAS), a pyridoxal 5'-phosphat
47                                            5-Aminolevulinate synthase (ALAS), the first enzyme of the
48 tes heme biosynthesis by activation of delta-aminolevulinate synthase (ALAS), which catalyzes the fir
49 imiting enzyme of heme biosynthesis is delta-aminolevulinate synthase (ALAS), which is localized in m
50 iting enzyme in hepatic heme biosynthesis, 5-aminolevulinate synthase (ALAS-1), is regulated by the p
51      The erythroid-specific isoform of delta-aminolevulinate synthase (ALAS-E) catalyzes the first st
52                                  Erythroid 5-aminolevulinate synthase (ALAS-E) catalyzes the first st
53 f-function mutations in erythroid-specific 5-aminolevulinate synthase (ALAS2), and new and experiment
54 odes the erythroid-specific isoform of delta-aminolevulinate synthase (ALAS2; also known as ALAS-E),
55                                            5-Aminolevulinate synthase (EC 2.3.1.37) (ALAS), a pyridox
56                                            5-Aminolevulinate synthase (EC 2.3.1.37) catalyzes the fir
57                                            5-Aminolevulinate synthase (EC 2.3.1.37) is the first enzy
58 he pyridoxal 5'-phosphate-dependent enzyme 5-aminolevulinate synthase (EC 2.3.1.37).
59 ced stabilization of the mRNA encoding delta aminolevulinate synthase 1 (ALAS1), the rate-limiting en
60 rough regulation of the rate-limiting enzyme aminolevulinate synthase 1 (Alas1).
61 enzymes of heme synthesis and degradation (5-aminolevulinate synthase 1 and heme oxygenase 1, respect
62                      Increased activity of 5-aminolevulinate synthase 2 (ALAS2) has been shown to adv
63  in the intron 1 GATA site (int-1-GATA) of 5-aminolevulinate synthase 2 (ALAS2) have been identified
64 e X chromosomal gene ALAS2, which encodes 5'-aminolevulinate synthase 2, in the affected females.
65 sults provide conclusive evidence that the 5-aminolevulinate synthase active site is located at the s
66 increased hepatic nonheme iron and hepatic 5-aminolevulinate synthase activity in Hfe(-/-) but not wi
67                              The wild-type 5-aminolevulinate synthase additionally forms a stable qui
68                                              Aminolevulinate synthase and circularly permuted variant
69 d by a combination of feedback inhibition of aminolevulinate synthase and diversion of aminolevulinat
70  IREs encoded by erythroid heme biosynthetic aminolevulinate synthase and Hif-2alpha mRNAs, which pre
71         Homology sequence modeling between 5-aminolevulinate synthase and some other alpha-family pyr
72                     Although the wild type 5-aminolevulinate synthase and the circularly permuted var
73 rall conformational stabilities varied among aminolevulinate synthase and variants.
74 e proposal that D279 plays a crucial role in aminolevulinate synthase catalysis by enhancing the elec
75 uinonoid intermediate formation during the 5-aminolevulinate synthase catalytic cycle.
76                                            5-Aminolevulinate synthase catalyzes the condensation of g
77                                            5-Aminolevulinate synthase catalyzes the first step of the
78                                            5-Aminolevulinate synthase catalyzes the pyridoxal 5'-phos
79 opped-flow experiments of murine erythroid 5-aminolevulinate synthase demonstrate that reaction with
80  demonstrated that circular permutation of 5-aminolevulinate synthase does not prevent folding of the
81 le activity as determined using a standard 5-aminolevulinate synthase enzyme-coupled activity assay.
82 e or when it is transformed with an active 5-aminolevulinate synthase expression plasmid, the hem A-
83 sine 313 (K313) of mature murine erythroid 5-aminolevulinate synthase forms a Schiff base linkage to
84 levulinic acid dehydratase (Alad), but not 5-aminolevulinate synthase gene (Alas2) or porphobilinogen
85 sed by mutations in the erythroid-specific 5-aminolevulinate synthase gene (ALAS2).
86 ssense mutations in the erythroid-specific 5-aminolevulinate synthase gene (ALAS2).
87 enhancers (HS-40 plus GATA-1 or HS-40 plus 5-aminolevulinate synthase intron 8 [I8] enhancers) and WP
88 ponding to the Arg-439 of murine erythroid 5-aminolevulinate synthase is a conserved residue in this
89                                            5-Aminolevulinate synthase is a dimeric protein having an
90 suggest that the conserved glycine loop in 5-aminolevulinate synthase is a pyridoxal 5'-phosphate cof
91                                            5-Aminolevulinate synthase is the first enzyme of the heme
92 equencing of four Saccharomyces cerevisiae 5-aminolevulinate synthase mutants, which lack ALAS activi
93 ite-directed, catalytically inactive mouse 5-aminolevulinate synthase mutants.
94 l and kinetic mechanisms and indicate that 5-aminolevulinate synthase operates under the stereoelectr
95                        To assess whether the aminolevulinate synthase overall structure can be reache
96 ther, the data lead us to propose that the 5-aminolevulinate synthase overall structure can be reache
97 dicates that the natural continuity of the 5-aminolevulinate synthase polypeptide chain and the seque
98 , much less is known about the role of the 5-aminolevulinate synthase polypeptide chain arrangement i
99 played unique circular permutations of the 5-aminolevulinate synthase polypeptide chain.
100 e 149, a conserved residue among all known 5-aminolevulinate synthase sequences, is essential for fun
101 f the catalytic domain of all members of the aminolevulinate synthase superfamily of proteins of whic
102 nal structure, active, circularly permuted 5-aminolevulinate synthase variants possess different topo
103 the polypeptide chain, circularly permuted 5-aminolevulinate synthase variants were constructed throu
104 as increased approximately twofold and delta-aminolevulinate synthase was increased approximately 50%
105 e, Arg-439 and Arg-433 of murine erythroid 5-aminolevulinate synthase were each replaced by Lys and L
106 ochelatase, porphobilinogen deaminase, and 5-aminolevulinate synthase) containing CACCC elements or G
107 ochelatase, porphobilinogen deaminase, and 5-aminolevulinate synthase).
108 ncreases in the mRNAs of cytochrome c, delta-aminolevulinate synthase, and citrate synthase also occu
109 RNA) or a C-bulge (in m-aconitase, erythroid aminolevulinate synthase, and transferrin receptor mRNAs
110 d in substrate binding in murine erythroid 5-aminolevulinate synthase, Arg-439 and Arg-433 of murine
111                         In mouse erythroid 5-aminolevulinate synthase, lysine 313 has been identified
112 hat in the active site of murine erythroid 5-aminolevulinate synthase, R439 is contributed from the s
113 e in substrate binding of murine erythroid 5-aminolevulinate synthase.
114  other respiratory chain subunits, and delta-aminolevulinate synthase.
115 pendent condensation reaction catalyzed by 5-aminolevulinate synthase.
116 ences different from that of the wild type 5-aminolevulinate synthase.
117 roid enzyme was found to be conserved in all aminolevulinate synthases and appeared to be homologous
118 protein molecule for the activation of delta-aminolevulinate synthetase.
119 nonoid intermediate formed upon binding of 5-aminolevulinate to the wild-type enzyme indicated that t
120 ated with non-AFXL (median, 2898 AU), methyl aminolevulinate-treated controls (median, 2254 AU), and
121 as demonstrated that less than 20% of [(14)C]aminolevulinate was incorporated into bacteriochlorophyl
122               The slow rate of reaction of 5-aminolevulinate with ALAS is 5-aminolevulinate-independe
123              Reaction of either glycine or 5-aminolevulinate with ALAS is slow (kf = 0.15 s-1) and ap

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top